MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Corcept Therapeutics Incorporated EV 2011-2026 | CORT
EV Jährlich Corcept Therapeutics Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.58 B | 2.52 B | 2.25 B | 2.26 B | 2.99 B | 1.5 B | 1.34 B | 2.69 B | 794 M | 383 M | 308 M | 360 M | 138 M | 249 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.58 B | 138 M | 1.74 B |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.82 B | - | 2.43 % | $ 254 M |  Germany |
 |
ARCA biopharma
ABIO
|
436 M | - | 1052.0 % | $ 415 M |  USA |
 |
Adaptive Biotechnologies Corporation
ADPT
|
1.47 B | $ 18.38 | -0.68 % | $ 2.7 B | USA |
 |
Amgen
AMGN
|
145 B | $ 344.65 | 0.81 % | $ 185 B | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
6.02 B | $ 71.99 | 3.84 % | $ 9.63 B | USA |
 |
Biogen
BIIB
|
28.3 B | $ 178.18 | -0.95 % | $ 25.9 B | USA |
 |
I-Mab
IMAB
|
8.28 B | - | - | $ 866 M |  China |
 |
Aytu BioScience
AYTU
|
-15.2 M | $ 2.65 | 1.92 % | $ 16.6 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
1.95 B | - | - | $ 40.3 B | USA |
 |
Adagene
ADAG
|
395 M | $ 2.96 | 7.64 % | $ 167 M | China |
 |
Biophytis SA
BPTS
|
525 M | - | -13.47 % | $ 169 M |  France |
 |
Burford Capital Limited
BUR
|
3.22 B | $ 9.83 | 1.44 % | $ 1.59 B |  Britain |
 |
Midatech Pharma plc
MTP
|
4.79 M | - | -18.52 % | $ 27.3 M | Britain |
 |
Can-Fite BioPharma Ltd.
CANF
|
647 M | $ 4.16 | 3.74 % | $ 9.05 B |  Israel |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
3.41 B | - | -1.52 % | $ 24.7 M | USA |
 |
Akero Therapeutics
AKRO
|
2.99 B | - | - | $ 3.67 B | USA |
 |
Alterity Therapeutics Limited
ATHE
|
-28.9 M | $ 3.18 | 0.32 % | $ 7.65 B |  Australia |
 |
Acorda Therapeutics
ACOR
|
-13.2 M | - | -24.86 % | $ 820 K | USA |
 |
Compugen Ltd.
CGEN
|
291 M | $ 1.86 | 1.1 % | $ 167 M | Israel |
 |
Aptose Biosciences
APTO
|
10.8 M | - | -45.71 % | $ 1.2 M |  Canada |
 |
Acasti Pharma
ACST
|
24 M | - | 4.01 % | $ 150 M | Canada |
 |
Celldex Therapeutics
CLDX
|
18.3 M | $ 24.86 | 1.06 % | $ 1.6 M | USA |
 |
Cellectis S.A.
CLLS
|
109 M | $ 3.87 | 2.22 % | $ 116 M | France |
 |
Aeglea BioTherapeutics
AGLE
|
725 M | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
486 M | $ 1.41 | - | $ 264 M | USA |
 |
Albireo Pharma
ALBO
|
417 M | - | -0.23 % | $ 916 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
14.1 M | - | - | - |  Russia |
 |
Allena Pharmaceuticals
ALNA
|
-14.1 M | - | 3.16 % | $ 1.9 M | USA |
 |
Ascendis Pharma A/S
ASND
|
726 M | $ 224.87 | -0.54 % | $ 5 B |  Danmark |
 |
Ampio Pharmaceuticals
AMPE
|
-1.05 M | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
7.6 M | - | - | $ 10.1 M | USA |
 |
Aravive
ARAV
|
58.2 M | - | -13.39 % | $ 1.45 M | USA |
 |
BioNTech SE
BNTX
|
-6.64 B | $ 110.01 | -3.29 % | $ 27.2 B | Germany |
 |
Athira Pharma
ATHA
|
-18.3 M | - | - | $ 269 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.52 M | - | 5.93 % | $ 314 M | Canada |
 |
Autolus Therapeutics plc
AUTL
|
1.11 B | $ 1.39 | 1.5 % | $ 355 M | Britain |
 |
AgeX Therapeutics
AGE
|
6.28 M | - | -10.17 % | $ 12.2 K | USA |
 |
AVROBIO
AVRO
|
-35.4 M | - | 1083.1 % | $ 745 M | USA |
 |
Cardiff Oncology
CRDF
|
157 M | $ 1.73 | -1.43 % | $ 82.4 M | USA |
 |
Akouos
AKUS
|
95.1 M | - | 0.23 % | $ 488 M | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
2.15 B | - | -15.15 % | $ 60.3 M | Britain |
 |
DBV Technologies S.A.
DBVT
|
636 M | $ 21.75 | 0.65 % | $ 2.11 B | France |
 |
Brickell Biotech
BBI
|
515 K | - | -5.38 % | $ 6.06 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
1.72 B | $ 14.25 | 4.13 % | $ 4.4 B | USA |
 |
AIkido Pharma
AIKI
|
22.8 M | - | 1.93 % | $ 17.4 M | USA |
 |
Atreca
BCEL
|
94.8 M | - | -11.76 % | $ 5.79 M | USA |
 |
CureVac N.V.
CVAC
|
3.19 B | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
38.2 M | - | 2.71 % | $ 14 M | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
2.58 B | $ 6.72 | 2.05 % | $ 1.39 B | USA |